Transcripts

Tonight: Merck and Pfizer, two giant pharmaceutical rivals, are now teaming up with a common goal – to combat a certain type of cancer.

Tonight: The S&P 500 breaks through 2,000 for the first time ever. Which sectors got the market to this point and which will lead the next leg?

Tonight: Fed Chair Janet Yellen says the economy is improving but not enough to worry the market about moving up the rate-hiking time table.

Tonight: As the S&P 500 closes at record levels, are you better off investing in an index fund that tracks the market or picking stocks?

Tonight: The debate over when the Federal Reserve will hike rates is intensifying and grabbing the attention of investors, Wall Street and Main Street.

Tonight: Homeowners poured money into renovation projects and that helped Home Depot’s bottom line. But is the trend expected to continue?

Tonight: No news was good news on Wall Street as a quiet August day ended with a 170-point gain on the Dow.

Tonight: The markets were rattled on reports of renewed fighting in Ukraine. What does it mean for your investments in stocks and bonds.

Tonight: A Warren Buffett milestone. Shares of his Berkshire Hathaway top $200,000 for the first time ever.

Tonight: The SEC is reportedly looking into a group of funds growing in popularity with small investors. The risks and rewards of investing in Alternative Mutual Funds.

Tonight: Retail earnings reports could drive the market later this week, but which is the one stock to own for the long term?

Tonight: With the situation in northern Iraq tense, why aren’t oil prices spiking? And, 10,000 baby boomers turn 65 every day and that could have a lasting impact on our economy. We begin a four-part series tonight called “Aging in America.”

Tonight: Why the stock market is being driven higher even as the world remains on edge. And want a higher credit score? It just became a bit easier to obtain.

Tonight: Lingering concerns over Europe’s economy, Ukraine and Iraq are creating turmoil in the markets. But is this a good thing for U.S. stocks as investors look for safe havens?

Tonight: Sprint shares fall almost 20% after ending its bid for T-Mobile. Now, the company has to find new growth the hard way. And, what happens when unapproved drugs are the only hope for very ill patients. Tonight we start a three-part series ‘desperate measures.’